Ultrafiltration process design and implementation

Process Scale Bioseparations for the Biopharmaceutical Industry

Volumn , Issue , 2006, Pages 297-332

  Lutz, Herb ^a   Raghunath, Bala ^a  

^a MILLIPORE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123422248     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Kurnik RTA, Yu W, Blank GS, Burton AR, Smith D, Athalye AM, and van Reis R. Buffer exchange using size exclusion chromatography, countercur-rent dialysis, and tangential flow filtration: models development and industrial application. Biotechnol. Bioeng., 1995; 45:149-157.
2. Vilker VL, Colton CK, and Smith KA. Concentration polarization in protein ultrafiltration. Part I: an optical shadowgraph technique for measuring concentration profiles near a membrane-solution interface. AIChE J., 1984; 27:632-637.
3. McDonogh RM, Bauser H, Stroh N, and Grauscoph U. Experimental in situ measurement of concentration polarization during ultra- and micro-filtration of bovine serum albumin and dextran blue solutions. J. Membr. Sci., 1995; 104:51-63.
4. Cheryan M. Ultrafiltration Handbook. Pennsylvania: Technomic Publishing Company, Inc., 1986.
5. Zydney AL. Concentration effects on membrane sieving: developmentofastag-nant film model incorporating the effect of solute-solute interactions. J. Membr. Sci., 1992; 68:183.
6. Saksena S. Protein Transport in Selective Membrane Filtration. Ph.D. Dissertation, U. Delaware, Fall 1995.
7. Tkacik G and Michaels S. A rejection profile test for UF membranes and devices. Biotechnology, 1991;9:941-946.
8. Mitra G and Lundblad JL. Ultrafiltration of immune serum globulin and human serum albumin: regression analysis studies. Sep. Sci. Technol., 1978; 13:89-94.
9. Vilker VLC, ColtonCK, Smith KA, and Green DL. The osmotic pressure of concentrated protein and lipoprotein solutions and its significance to ultrafiltration. J. Membr. Sci., 1984; 20:63-77.
10. Schwinge J, Wiley DE, and Fletcher DF. Simulation of the flow around spacer filaments between channel walls. 2. Mass-transfer enhancement. Ind. Eng. Chem. Res., 2002; 41:4879-4888.
11. van Reis R, Goodrich EM, Yson CL, Frautschy LN, Whiteley R, and Zydney AL. Constant Cwall ultrafiltration process control. J. Membr. Sci., 1997; 130: 123-140.
12. Charm SE and Wong BL. Shear effects on enzymes. Enzyme Microb. Technol., 1981; 3:111-118.
13. Thomas CR and Dunnill P. Action of shear on enzymes: studies with catalase and urease. Biotechnol. Bioeng., 1979; 21:2279-2302.
14. Maa Y-F and Hsu CC. Effect of high shear on proteins. Biotechnol. Bioeng., 1996; 51:458-465.
15. Virkar PD, Narendranathan TJ, Hoare M, and Dunnill P. Studies of the effects of shear on globular proteins: Extension to high shear fields and pumps. Biotechnol. Bioeng., 1981; 23:425-429.
16. Millipore Corporation. Filter Sizing Methods. Lit No AN1512EN00, 2000.
17. Ng P, Lundblad L, and Mitra G. Optimization of solute separation by diafiltration. Sep. Sci., 1976; 2:499-502.
18. Millipore Corporation. Techniques for Demonstrating Cleaning Effectiveness of Ultrafiltration Membranes. Lit No TB1502EN00, 2000.
19. van Reis R, Goodrich EM, Yson CL, Frautschy LN, Dzengeleski S, and Lutz H. Linear scale ultrafiltration. Biotechnol. Bioeng., 1997; 55:737-746.
20. Frenz, J. Genentech. Personal communication. 1998.
21. Levenspiel O. Chemical Reaction Engineering. 2nd ed. New York: John Wiley & Sons, 1972, p. 97.
22. Mir L, Michaels SL, Goel V, and Kaiser R. Crossflow microfiltration: Applications, design, and cost. In: Ho WSW and Sirkar KK, Eds. Membrane Handbook. New York: Van Nostrand Reinhold, 1992.
23. Millipore Corporation. Protein Concentration and Diafiltration by Tangential Flow Filtration. Lit No TB032 Rev. B. 1999.
24. American Society of Mechanical Engineers. Bioprocess Equipment Guidelines. 1997.
25. Van Dyke M. An Album of Fluid Motion. Stanford, CA: Parabolic Press, 1982.
26. DeLucia D. Fundamentals of CIP Design. ASME Bioprocessing Seminars. 1997.
27. Peters M and Timmerhaus KD. Plant Design and Economics for Chemical Engineers. 2nd ed. New York: McGraw-Hill, 1968.
28. Ogez, J. Increasing Plant Capacity Using Buffer Concentrates & Linked Unit Operations. IBC 2nd Annual Recovery & Purification of Biopharmaceuticals, San Diego, CA, November 15, 2001.
29. ISPE. Baseline Guide Vol 5, Commissioning and Qualification. Tampa, FL: International Society for Pharmaceutical Engineering, 2001.
30. PDA. Industrial Perspective on Validation of Tangential Flow Filtration in Biopharmaceutical Applications. Technical report No. 15, Bethesda, MD: Parenteral Drug Association, 1992.
31. Petrone J, Erdenberger T, and Esenther C. Process Validation for Monitoring the Performance of Reusable Tangential Flow Filtration Membrane Devices. ACS Annual Meeting New Orleans, LA, March 2003.
32. US FDA. Guidance for Industry: Comparability Protocols-Chemistry, Manufacturing, and Controls Information, Draft Guidance. Rockville, MD, Feb. 2003, www.fda.gov/cder/guidance/index.htm.
33. Ho WSW and Sirkar KK. Membrane Handbook. New York: Van Nostrand Reinhold, 1992.
34. Eykamp W. Section 22, Membrane separation processes. In: Perry RH and Green DW, Eds. Perry's Chemical Engineers' Handbook, 7th ed. New York: McGraw-Hill, 1997.
35. Millipore Corporation. Maintenance Procedures for Prostak™ Modules. Lit No P17513. 1990.
36. Zeman LJ and Zydney AL. Microfiltration and Ultrafiltration: Principles and Applications. New York: Marcel Dekker, 1996.
37. Deen WM. Hindered transport of large molecules in liquid-filled pores. AIChE J., 1987; 33:1409-1425.